¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"large cell lymphoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • myeloid cell
    °ñ¼ö¼¼Æ÷
  • myeloma cell
    °ñ¼öÁ¾¼¼Æ÷
  • myoepithelial cell
    ±Ù(À°)»óÇǼ¼Æ÷
  • myoid cell
    ±Ù(À°)À¯»ç¼¼Æ÷
  • marrow cell
    °ñ¼ö¼¼Æ÷
  • mast cell
    ºñ¸¸¼¼Æ÷
  • mast cell degranulation
    ºñ¸¸¼¼Æ÷Å»°ú¸³
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • mastoid air cell
    ²ÀÁö¹úÁý, À¯µ¹¹úÁý
  • matrix cell
    ¹ÙÅÁÁú¼¼Æ÷, ±âÁú¼¼Æ÷
  • memory B cell
    ±â¾ïB¼¼Æ÷
  • memory cell
    ¸é¿ª±â¾ï¼¼Æ÷
  • memory T cell
    ±â¾ïT¼¼Æ÷
  • Merkel cell-neurite complex
    ¸Þ¸£Ä̼¼Æ÷½Å°æµ¹±âº¹ÇÕ, Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷, ¸Þ»êÁö¿ò¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • primed cell
    ÃÊȸ°¨ÀÛ¼¼Æ÷
  • primordial germ cell
    ¿ø½ÃÁ¾ÀÚ¼¼Æ÷
  • principal cell
    ÁÖ¼¼Æ÷
  • Purkinje cell
    ½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, Á¶·Õ¹Ú¼¼Æ÷
  • pyramidal cell
    ÇǶó¹Ô¼¼Æ÷
  • receptor cell
    ¼ö¿ëü¼¼Æ÷
  • red blood cell
    ÀûÇ÷±¸
  • reserve cell
    ¿¹ºñ¼¼Æ÷
  • residential cell
    Á¤ÁÖ¼¼Æ÷
  • resting cell
    ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
  • reticular cell
    ±×¹°¼¼Æ÷
  • reticuloendothelial cell
    ±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
  • reticulum cell
    (¢¡reticular cell) ±×¹°¼¼Æ÷
  • rod cell
    ¸·´ë¼¼Æ÷
  • rod shaped cell
    ¸·´ë¸ð¾ç¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • immunity,cell-mediated
    ¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
  • immunocompetent cell
    ¸é¿ªÀû°Ý¼¼Æ÷.
  • immunodeficiency syndrome, cell mediated
    ¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
  • immunologically committed cell
    ¸é¿ª°æÇè¼¼Æ÷(¡­ÌèúÐá¬øà).
  • immunologically competent cell
    ¸é¿ªÀû°Ý¼¼Æ÷(¡­îêÌ«á¬øà).
  • immunologically performing cell
    ¸é¿ª¼öÇ༼Æ÷(¡­âÄú¼á¬øà).
  • indeterminate cell
    ºÎÁ¤Çü(ÜôïÒû¡) ¼¼Æ÷(á¬øà)
  • indifferent cell
    ¹«°ü¼¼Æ÷.
  • indirect cell division
    °£Á¢¼¼Æ÷ºÐ¿­.
  • inducer T cell
    À¯µµ T ¼¼Æ÷
  • inner cell mass
    ³»¼¼Æ÷A(Ò®á¬øàÎÔ).
  • inner cell mass (embryoblast)
    ¼Ó¼¼Æ÷µ¢ÀÌ ¹èÀÚ¸ðü
  • inner cell mass embryoblast
    ¼Ó¼¼Æ÷µ¢ÀÌ ¹èÀÚ¸ðü
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷(Ò®êáÙ¾á¬øà).
  • inner hair cell
    ¼ÓÅм¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • cell line
    ¼¼Æ÷°è(á¬øàͧ).
  • cell line, established
    È®¸³¼¼Æ÷ÁÖ
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • cell loss factor
    ¼¼Æ÷¼Ò½Ç°è¼ö
  • cell lysis
    ¼¼Æ÷¿ëÇØ
  • cell mass
    ¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
  • cell mass
    ¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
  • cell matrix
    ¼¼Æ÷±âÁú
  • cell maturation
    ¼¼Æ÷¼º¼÷
  • cell mediated hypersensitivity
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • cell mediated immunity
    ¼¼Æ÷¼º¸é¿ª.
  • cell mediated immunity deficiency syndrome
    ¼¼Æ÷(¸Å°³)¸é¿ª°áÇÌÁõÈıº.
  • cell mediated immunity deficiency syndrome
    ¼¼Æ÷¼º¸é¿ª°áÇÌÁõÈıº.
  • cell mediated lympholysis
    ¼¼Æ÷¸Å°³ ¸²ÇÁ±¸¿ëÇØ
  • cell mediated reaction
    ¼¼Æ÷¸Å°³¼º ¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
LGI large glucagon immunoreactivity; low gastrointestinal
LGL-NK large granular lymphocyte-natural killer
LGV large granular vesicle; lymphogranuloma venereum
LI labeling index; lactose intolerance; lacunar infarct; lamellar ichthyosis; Langerhans islet; large i...
LID large intraluminal density; late immunoglobulin deficiency; lymphocytic infiltrative disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
LAK cell lymphokine activated killer cell
M cell Mauthner cell
NK cell natural killer cell
P-cell Purkinje cell
APC T-cell-antigen-presenting cell
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • peritubal cell
    À̰ü ÁÖÀ§ ºÀ¼Ò
  • perivascular cell
    Ç÷°ü ÁÖÀ§ ¼¼Æ÷
  • phagocytic synovial cell
    Æ÷½Ä À±È° ¼¼Æ÷
  • physiological cell
    »ý¸® ¼¼Æ÷
  • pigment cell nevus
    »ö¼Ò ¼¼Æ÷ ¸ð¹Ý
  • plasma cell
    ÇüÁú±¸, Ç÷Àå ¼¼Æ÷, ÇüÁú ¼¼Æ÷
    1. Ç×ü¸¦ ºÐºñÇÒ ¼ö ÀÖ´Â ¼¼Æ÷. 2. ¸¸¼º ¿°ÁõÀ̳ª ƯÁ¤ Áúȯ »óÅÂ, ¶Ç´Â Á¾¾ç¿¡¼­ ³ªÅ¸³ª´Â ¼¼Æ÷·Î ¼øÈ¯ Ç÷¾×¿¡ Á¤»óÀûÀ¸·Î ³ªÅ¸³ªÁö´Â ¾Ê´Â´Ù. Å©±â´Â Àӯı¸º¸´Ù Å©¸ç, È£¿°±â¼ºÀÇ ¿°»öÁúÀ» °¡Áö´Â ÇÙÀÌ ¼¼Æ÷ÀÇ Á߽ɿ¡¼­ ¹þ¾î³ª ½Ã°èÀÇ ¼ýÀÚÆÇÀÇ ¼ýÀÚµéó·³ º¯¿¬¿¡ À§Ä¡Çϰí ÀÖ´Ù. ÀÌ ¼¼Æ÷ÀÇ ±â¿ø¿¡ °üÇØ¼­´Â
  • plasma cell dyscrasia
    Ç÷Àå ¼¼Æ÷ ÀÌ»ó
  • plasma cell pneumonia
    ÇüÁú ¼¼Æ÷¼º Æó·Å
  • pleomorphic cell
    ´ÙÇü ¼¼Æ÷
  • pluripotential stem cell
    ´Ù´É¼º °£ ¼¼Æ÷
  • PNH cell
    PNH ¼¼Æ÷
    ¹ßÀÛ¼º ¾ß°£ Ç÷»ö´¢Áõ¿¡¼­ º¸ÀÌ´Â ÀûÇ÷±¸. ÀÌµé ¼¼Æ÷´Â Á¤»ó ¶Ç´Â Á¤»ó À¯»ç ¼¼Æ÷
  • polyhedral cell
    ¹µ¸éü ¼¼Æ÷
  • postmitotic maturing cell
    °¨¼öºÐ¿­ ÈÄ ¼º¼÷ ¼¼Æ÷
  • prickel cell
    ±Ø ¼¼Æ÷
  • prickle cell carcinoma
    ±Ø¼¼Æ÷ ¾Ï
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
giant cell tumours Tumours of bone tissue or synovial or other soft tissue characterised by the presence of giant cells. The most common are giant cell tumour of tendon sheath and giant cell tumour of bone.
(12 Dec 1998)
red blood cell <haematology> Cell specialised for oxygen transport, having a high concentration of haemoglobin in the cytoplasm (and little else). Biconcave, anucleate discs, 7nm diameter in mammals, nucleus contracted and chromatin condensed in other vertebrates.
Acronym: RBC
(18 Nov 1997)
red blood cell cast A urinary cast composed of a matrix containing red cells in various stages of degeneration and visibility, characteristic of glomerular disease or renal parenchymal bleeding.
Synonym: red cell cast.
(05 Mar 2000)
red blood cell count A normal value is 4.6-6.2 million RBC's per cubic millimetre of blood. This number can increase in cases of dehydration (fluid loss) or severe lung disease. Interestingly, red blood cell counts are much higher in those who live at high altitude, because of the increased demand for oxygen carrying capacity.
(27 Sep 1997)
red blood cell indices Laboratory measurements of red blood cell volume, size and haemoglobin concentration. These values are used to point to the specific cause for anaemia (iron deficiency, B12 deficiency, etc.)
(27 Sep 1997)
red cell adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
red cell adherence test The diagnostic application of the immune adhesion phenomenon.
Synonym: erythrocyte adherence test, immune adhesion test, red cell adherence test.
(05 Mar 2000)
red-cell aplasia, pure Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
(12 Dec 1998)
red cell cast A urinary cast composed of a matrix containing red cells in various stages of degeneration and visibility, characteristic of glomerular disease or renal parenchymal bleeding.
Synonym: red cell cast.
(05 Mar 2000)
Reed-Sternberg cell <haematology, pathology> A type of cell that appears in patients with Hodgkin's disease. The number of these cells increases as the disease advances.
(12 May 1997)
viable cell count Number of cells in a given area or volume that are thriving.
(05 Mar 2000)
mature cell leukaemia Chronic granulocytic leukaemia.
(05 Mar 2000)
Mauthner's cell <marine biology> A large neuron of the spinal cord with its cell body located in the metencephalon of fish and amphibia.
(05 Mar 2000)
caterpillar cell A large mononuclear cell found in connective tissue of the heart wall in inflammatory conditions, especially in the Aschoff body. The ovoid nucleus contains a central chromatin mass appearing as a wavy bar in longitudinal section.
Synonym: Anitschkow cell, Anitschkow myocyte, caterpillar cell.
(05 Mar 2000)
gitter cell A lipid-laden microglial phagocyte commonly seen at the edge of healing brain infarcts, a result of cellular phagocytosis of lipid from necrotic or degenerating brain cells.
Synonym: compound granule cell.
Origin: Ger. Gitterzelle, fr. Gitter, lattice, wire-net
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á